How UHN & Eli Lilly Are Building a Translational Ecosystem to Accelerate Radiopharmaceutical Development
11:30 am - Tuesday 1st December 2026
- Sharing how integrated translational infrastructure is accelerating radiopharmaceutical development from discovery through to standard of care
- Exploring the operational foundations required to support Phase 0 studies, clinical trials and therapeutic innovation
- Identifying the capabilities needed to translate promising radiopharmaceuticals into routine clinical practice